D. Ponce

发表

Inpatient Management of Mucocutaneous GVHD

A. Markova, Toral S. Vaidya, C. Menzer, 2019, Current Dermatology Reports.

Establishing a standardized system for review and adjudication of chronic graft‐vs‐host disease data in accordance with the National Institutes Consensus criteria

M. Perales, C. Ciolino, S. Prockop, 2019, Advances in cell and gene therapy.

Ex Vivo CD34+-Selected T Cell-Depleted Peripheral Blood Stem Cell Grafts for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Leukemia and Myelodysplastic Syndrome Is Associated with Low Incidence of Acute and Chronic Graft-versus-Host Disease and High Treatment Response.

J. Goldberg, M. Perales, M. V. D. van den Brink, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes between CD34+ Selected and Unmodified Hematopoietic Stem Cell Transplantation.

M. Perales, S. Devlin, B. Andersson, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A novel reduced-intensity conditioning regimen induces a high incidence of sustained donor-derived neutrophil and platelet engraftment after double-unit cord blood transplantation.

J. Goldberg, M. Perales, S. Devlin, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

MAIT and Vδ2 unconventional T cells are supported by a diverse intestinal microbiome and correlate with favorable patient outcome after allogeneic HCT

Anastasia I. Kousa, A. Bush, M. Perales, 2022, Science Translational Medicine.

Geriatric syndromes in 2-year, progression-free survivors among older recipients of allogeneic hematopoietic cell transplantation

M. Perales, A. Shahrokni, R. Baser, 2020, Bone Marrow Transplantation.

Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant

E. Robilotti, Cesar J. Figueroa, S. Morjaria, 2018, Science Translational Medicine.

Low-dose unfractionated heparin prophylaxis is a safe strategy for the prevention of hepatic sinusoidal obstruction syndrome after myeloablative adult allogenic stem cell transplant

J. Goldberg, M. Perales, S. Devlin, 2022, Bone Marrow Transplantation.

Racial disparities in access to HLA-matched unrelated donor transplants: a prospective 1312-patient analysis.

S. Devlin, A. Scaradavou, S. Giralt, 2019, Blood advances.

Robust Vaccine Responses in Adult and Pediatric Cord Blood Transplantation Recipients Treated for Hematologic Malignancies.

G. Papanicolaou, M. Perales, S. Devlin, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reduced-intensity conditioning hematopoietic stem cell transplantation for chronic lymphocytic leukemia and Richter's transformation.

A. Zelenetz, M. Perales, S. Devlin, 2021, Blood advances.

TRANSPLANTATION The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation

A. Viale, S. Morjaria, Y. Taur, 2014 .

Favorable long-term outcomes of hematopoietic stem cell transplantation for CMML with myeloablative conditioning, anti-thymocyte globulin, and CD34+ selected graft

M. Perales, S. Devlin, James W. Young, 2019, Bone Marrow Transplantation.

Oral Proteasome Inhibitor Ixazomib for Switch-Maintenance Prophylaxis of Recurrent or Late Acute and Chronic Graft-versus-Host Disease after Day 100 in Allogeneic Stem Cell Transplantation.

M. Perales, S. Devlin, S. Giralt, 2021, Transplantation and cellular therapy.

Combining the disease risk index and hematopoietic cell transplant co‐morbidity index provides a comprehensive prognostic model for CD34+‐selected allogeneic transplantation

M. Perales, James W. Young, J. Peled, 2020, Advances in cell and gene therapy.

Long-term prognosis for 1-year relapse-free survivors of CD34 cell–selected allogeneic hematopoietic stem cell transplantation: a landmark analysis

M. Perales, M. V. D. van den Brink, S. Devlin, 2017, Bone Marrow Transplantation.

Ex Vivo T Cell-Depleted Hematopoietic Stem Cell Transplantation for Adult Patients with Acute Myeloid Leukemia in First and Second Remission: Long-Term Disease-Free Survival with a Significantly Reduced Risk of Graft-versus-Host Disease.

M. Perales, James W. Young, S. Giralt, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

High progression-free survival after intermediate intensity double unit cord blood transplantation in adults.

M. Perales, S. Devlin, K. Hsu, 2020, Blood advances.

Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant

A. Goldberg, M. Perales, M. Tallman, 2021, Leukemia & lymphoma.

Engraftment Kinetics after Transplantation of Double Unit Cord Blood Grafts Combined with Haplo-identical CD34+ Cells without Anti-thymocyte Globulin

M. Arcila, M. Perales, S. Devlin, 2020, Leukemia.

Acute GVHD Diagnosis and Adjudication in a Multicenter Trial: A Report From the BMT CTN 1202 Biorepository Study

J. Bolaños-Meade, Yi-Bin Chen, J. Hansen, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dominant unit CD34+ cell dose predicts engraftment after double-unit cord blood transplantation and is influenced by bank practice.

S. Devlin, A. Scaradavou, S. Giralt, 2014, Blood.

Dominant unit CD 34 1 cell dose predicts engraftment after double-unit cord blood transplantation and is in fl uenced by bank practice

S. Devlin, A. Scaradavou, S. Giralt, 2014 .

Establishing a Standardized System to Capture Chronic GRAFT-Versus-Host Disease (GVHD) DATA in Accordance to the National Institutes of Health (NIH) Consensus Criteria

M. Perales, C. Ciolino, S. Prockop, 2018 .

Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies

G. Salles, A. Zelenetz, S. Seo, 2022, Cancer Cell.

CD34+ -selected hematopoietic stem cell transplant conditioned with a myeloablative regimen in patients with advanced myelofibrosis

M. Perales, S. Devlin, S. Giralt, 2022, Bone Marrow Transplantation.

Improved GRFS after posttransplant cyclophosphamide-based vs ATG-based HLA-mismatched unrelated donor transplant

M. Perales, S. Devlin, L. Lekakis, 2022, Blood advances.

Low dose Unfractionated Heparin Prophylaxis is a Safe Strategy for the Prevention of Hepatic Sinusoidal Obstruction Syndrome After Myeloablative Adult Allogenic Stem Cell Transplant

J. Goldberg, M. Perales, S. Devlin, 2022, Bone Marrow Transplantation.

High Disease-Free Survival and Enhanced Protection Against Relapse after Double-Unit Cord Blood Transplantation (DCB-T) When Compared to Unrelated Donor Transplantation (URD-T) in Patients with Acute Leukemia, MDS and CML

J. Goldberg, M. Perales, S. Devlin, 2014 .

Graft-versus-host disease after double-unit cord blood transplantation has unique features and an association with engrafting unit-to-recipient HLA match.

J. Goldberg, M. Perales, R. Jenq, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A Phase 2 Study of F-652, a Novel Tissue-Targeted Recombinant Human Interleukin-22 (IL-22) Dimer, for Treatment of Newly Diagnosed Acute Gvhd of the Lower GI Tract

M. V. D. van den Brink, J. Shia, A. Alousi, 2020 .

The Hematopoietic Cell Transplant-Co-Morbidity Index (HCT-CI) Predicts Outcomes After T Cell Depleted (TCD) Allogeneic HCT For AML and MDS

J. Goldberg, M. Perales, S. Devlin, 2013 .

Characteristics and Impact of Post-Transplant Interdisciplinary Palliative Care Consultation in Older Allogeneic Hematopoietic Cell Transplant Recipients.

M. Perales, S. Devlin, J. Nelson, 2020, Journal of palliative medicine.

Racial disparities in access to alternative donor allografts persist in the era of “donors for all”

M. Perales, James W. Young, A. Scaradavou, 2021, Blood advances.

Real-time Reflectance Confocal Microscopy of Cutaneous Graft-versus-Host Disease Correlates with Histopathology.

S. Dusza, M. Ardigó, J. Monnier, 2021, Transplantation and cellular therapy.

Hematopoietic cell transplantation outcomes are linked to intestinal mycobiota dynamics and an expansion of Candida parapsilosis complex species

T. Rolling, T. Hohl, Y. Taur, 2021, Nature Microbiology.

Intestinal fungal dynamics and linkage to hematopoietic cell transplantation outcomes.

T. Rolling, T. Hohl, Y. Taur, 2021, medRxiv.

A novel reduced intensity conditioning regimen for patients with high-risk hematological malignancies undergoing allogeneic stem cell transplantation

J. Goldberg, M. Perales, G. Hobbs, 2016, Bone Marrow Transplantation.

Sirolimus, tacrolimus and low-dose methotrexate based graft-versus-host disease prophylaxis after non-ablative or reduced intensity conditioning in related and unrelated donor allogeneic hematopoietic cell transplant

J. Goldberg, M. Perales, S. Devlin, 2015, Leukemia & lymphoma.

Incidence, nature and mortality of cytomegalovirus infection after double-unit cord blood transplant

G. Papanicolaou, M. Perales, S. Devlin, 2015, Leukemia & lymphoma.

Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin.

G. Papanicolaou, M. Perales, S. Devlin, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation.

A. Viale, S. Morjaria, Y. Taur, 2014, Blood.

CD34-Selected Hematopoietic Stem Cell Transplants Conditioned with Myeloablative Regimens and Antithymocyte Globulin for Advanced Myelodysplastic Syndrome: Limited Graft-versus-Host Disease without Increased Relapse.

J. Goldberg, M. Perales, S. Devlin, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Microbe-derived short chain fatty acids butyrate and propionate are associated with protection from chronic GVHD.

Amanda J. Pickard, Y. Taur, A. Bush, 2020, Blood.

Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation.

Daigo Hashimoto, Robert R Jenq, Amy Bush, 2020, The New England journal of medicine.

Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease.

Y. Taur, E. Pamer, J. Goldberg, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Intensified Mycophenolate Mofetil Dosing and Higher Mycophenolic Acid Trough Levels Reduce Severe Acute Graft-versus-Host Disease after Double-Unit Cord Blood Transplantation.

M. Perales, R. Jenq, M. V. D. van den Brink, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Lactose drives Enterococcus expansion to promote graft-versus-host disease

Amanda J. Pickard, Y. Taur, A. Bush, 2019, Science.

Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation.

R. Khanin, Y. Taur, E. Pamer, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplant.

J. Teruya-Feldstein, M. Arcila, M. Perales, 2020, The Journal of clinical investigation.

Prospective Evaluation of Unrelated Donor Cord Blood and Haploidentical Donor Access Reveals Graft Availability Varies by Patient Ancestry: Practical Implications for Donor Selection.

M. Perales, S. Devlin, A. Scaradavou, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Autoimmune hemolysis and immune thrombocytopenic purpura after cord blood transplantation may be life-threatening and warrants early therapy with rituximab

M. Perales, S. Devlin, A. Scaradavou, 2016, Bone Marrow Transplantation.

Guidelines for the Prevention and Management of Graft-versus-Host Disease after Cord Blood Transplantation.

M. MacMillan, A. Alousi, M. Horwitz, 2021, Transplantation and cellular therapy.

Reduced late mortality risk contributes to similar survival after double-unit cord blood transplantation compared with related and unrelated donor hematopoietic stem cell transplantation.

M. Perales, R. Jenq, M. V. D. van den Brink, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

High Disease-Free Survival with Enhanced Protection against Relapse after Double-Unit Cord Blood Transplantation When Compared with T Cell-Depleted Unrelated Donor Transplantation in Patients with Acute Leukemia and Chronic Myelogenous Leukemia.

M. Perales, M. V. D. van den Brink, S. Devlin, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Double-Unit Cord Blood (CB) Transplantation (DCBT) Combined with Haplo-Identical Peripheral Blood CD34+ Cells (HaploCD34+) Is Associated with Enhanced Neutrophil Recovery, Universal Haplo Rejection, and Frequent Pre-Engraftment Syndrome

M. Perales, James W. Young, A. Scaradavou, 2015 .

Donor–recipient allele-level HLA matching of unrelated cord blood units reveals high degrees of mismatch and alters graft selection

S. Devlin, A. Scaradavou, S. Giralt, 2014, Bone Marrow Transplantation.

"No wash" albumin-dextran dilution for double-unit cord blood transplantation is safe with high rates of sustained donor engraftment.

S. Devlin, A. Scaradavou, S. Giralt, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hematopoietic Cell Transplantation is Feasible in Patients with Prior COVID-19 Infection

G. Papanicolaou, M. Kamboj, M. Perales, 2021, Transplantation and Cellular Therapy.

Clinical Research : Alternative Donors Intensi fi ed Mycophenolate Mofetil Dosing and Higher Mycophenolic Acid Trough Levels Reduce Severe Acute Graft-versus-Host Disease after Double-Unit Cord Blood Transplantation

M. Perales, R. Jenq, S. Devlin, 2022 .

Analysis of Cyclosporine A Levels Supports New Dosing Guidelines in Adult Double-Unit Cord Blood Transplant Recipients to Optimize Immunosuppression Early Post-Transplant.

J. Barker, D. Ponce, A. Lin, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

In Vivo T Cell Depletion with Myeloablative Regimens on Outcomes after Cord Blood Transplantation for Acute Lymphoblastic Leukemia in Children.

J. Wagner, M. Perales, R. Sparapani, 2015, Biology of Blood and Marrow Transplantation.

High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation.

J. Goldberg, M. Perales, R. Jenq, 2015, Blood.

EASIX score predicts inferior survival after allogeneic hematopoietic cell transplantation

M. Perales, S. Devlin, S. Giralt, 2023, Bone Marrow Transplantation.

The use of back-up units to enhance the safety of unrelated donor cord blood transplantation.

G. Heller, A. Scaradavou, S. Giralt, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Double-Unit Cord Blood (CB) Transplantation Combined with Haplo-Identical CD34+ Cells Results in 100% CB Engraftment with Enhanced Myeloid Recovery

J. Goldberg, M. Perales, S. Devlin, 2014 .

Double-Unit Cord Blood (CB) Transplantation Combined With Haplo-Identical CD34+ Cell-Selected PBSC Results In 100% CB Engraftment With Enhanced Myeloid Recovery

J. Goldberg, M. Perales, S. Devlin, 2013 .

Sustained donor engraftment in recipients of double-unit cord blood transplantation is possible despite donor-specific human leukoctye antigen antibodies.

S. Devlin, A. Scaradavou, S. Hsu, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Sustained Donor Engraftment in Recipients of Double-Unit Cord Blood Transplantation is Possible Despite Donor-Specific HLA- Antibodies

S. Devlin, A. Scaradavou, Jonathan Barone, 2014 .

Association between Nondominant Unit Total Nucleated Cell Dose and Engraftment in Myeloablative Double-Unit Cord Blood Transplantation.

James W. Young, A. Scaradavou, A. Hanash, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Relapse after allogeneic stem cell transplantation of acute myeloid leukemia and myelodysplastic syndrome and importance of second cellular therapy.

A. Goldberg, M. Perales, S. Devlin, 2021, Transplantation and cellular therapy.

Cellular Therapy During COVID-19: Lessons Learned and Preparing for Subsequent Waves

E. Robilotti, M. Kamboj, M. Perales, 2021, Transplantation and Cellular Therapy.

CD34-selected allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in the tyrosine kinase era

M. Perales, S. Giralt, A. Jakubowski, 2022, Bone Marrow Transplantation.

Allogeneic stem cell transplantation for advanced myelodysplastic syndrome: Comparison of outcomes between CD34 + selected or unmodified hematopoietic stem cells transplants

M. Perales, B. Andersson, U. Popat, 2019 .

Fractionated Infusion of Hematopoietic Progenitor Cells Does Not Improve Neutrophil Recovery or Survival in Allograft Recipients.

M. Perales, S. Devlin, James W. Young, 2021, Transplantation and cellular therapy.

Hematopoietic Cell Transplantation Comorbidity Index Predicts Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Receiving CD34+ Selected Grafts for Allogeneic Hematopoietic Cell Transplantation.

M. Perales, M. V. D. van den Brink, S. Devlin, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A phase 2 study of Interleukin-22 and systemic corticosteroids as initial treatment for acute GVHD of the lower GI tract.

M. Perales, M. V. D. van den Brink, S. Devlin, 2022, Blood.

The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCT

M. Perales, M. V. D. van den Brink, A. Nagler, 2021, Blood advances.

Analysis of Disparities in Time to Allogeneic Transplantation in Adults with Acute Myelogenous Leukemia.

M. Perales, S. Devlin, James W. Young, 2022, Blood advances.

Scalable Log-ratio Lasso Regression Enhances Microbiome Feature Selection for Predictive Models

Nicholas R. Waters, M. Gönen, M. Perales, 2023, bioRxiv.

Transplant Characteristics and Outcomes of Philadelphia (Ph)-like Acute Lymphoblastic Leukemia (ALL)

M. Arcila, M. Perales, T. Anagnostou, 2020 .

A phase 1b study to evaluate safety, tolerability, pharmacokinetics, and efficacy of SER-155 in adults undergoing hematopoietic stem cell transplantation to reduce the risk of infection and graft versus host disease (NCT04995653).

M. V. D. van den Brink, J. Peled, M. Lombardo, 2022, Journal of Clinical Oncology.

Preservation of fecal microbiome is associated with reduced severity of Graft-versus-Host Disease.

Y. Taur, M. Perales, M. V. D. van den Brink, 2022, Blood.

Acute Gvhd Diagnosis and Adjudication in a Multicenter Trial – a Report from the BMT CTN 1202 Biorepository Study

Yi-Bin Chen, J. Hansen, W. Saber, 2019, Biology of Blood and Marrow Transplantation.

Disease Progression is Main Barrier to Allogeneic Hematopoietic Stem Cell Transplantation (HCT) in Patients with Newly Diagnosed and Relapsed Acute Leukemia

M. Perales, M. Tallman, S. Giralt, 2018 .

Disease-Free Survival After Cord Blood (CB) Transplantation Is Not Different to That After Related or Unrelated Donor Transplantation in Patients with Hematologic Malignancies.

M. Perales, R. Jenq, K. Hsu, 2009 .

Loss of Microbiota Diversity after Autologous Stem Cell Transplant Is Comparable to Injury in Allogeneic Stem Cell Transplant

E. Pamer, M. Perales, R. Jenq, 2018, Blood.

Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease

S. Grupp, E. Holler, Z. DeFilipp, 2023, Blood advances.

Outcomes of adult T-Cell leukemia/lymphoma with allogeneic stem cell transplantation: single-institution experience

H. Schoder, M. Perales, S. Horwitz, 2021, Leukemia & lymphoma.

Interim Results of a Pilot, Prospective, Randomized, Double-Blinded, Vehicle- and Comparator-Controlled Trial on Safety and Efficacy of a Topical Inhibitor of Janus Kinase 1/2 (Ruxolitinib INCB018424 Phosphate 1.5% Cream) for Non-Sclerotic and Superficially Sclerotic Chronic Cutaneous Graft-Versus-H

M. Lacouture, M. Perales, S. Dusza, 2021, Blood.

Tissue-specific features of the T cell repertoire after allogeneic hematopoietic cell transplantation in human and mouse

Nicholas R. Waters, Anastasia I. Kousa, N. Socci, 2023, Science Translational Medicine.

Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant

E. Robilotti, Cesar J. Figueroa, S. Morjaria, 2018, Science Translational Medicine.

M. Perales, M. V. D. van den Brink, S. Devlin, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.